Showing results (1751-1760 of 1,814) with videos related to
Sort By:
Pageof 182
Neurobiology of Disease|July 13, 2024
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognitionVincent Huin, David Blum, Violette Delforge, et al.The European Respiratory Journal|November 1, 2014
An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory diseaseSally J Singh, Milo A Puhan, Vasileios Andrianopoulos, et al.Oncotarget|December 5, 2014
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignanciesMatthias Scheffler, Marc Bos, Masyar Gardizi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancerA Kron, C Alidousty, M Scheffler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyValentino Conter, Maria Grazia Valsecchi, Gunnar Cario, et al.NPJ Genomic Medicine|April 23, 2026
Immuno-molecular features associated with exceptional recurrence-free survivorship from Ovarian Cancer in the pre-PARP eraFélix Blanc-Durand, Elisa Yaniz Galende, Gwénaël Ferron, et al.Nature Medicine|August 7, 2025
Geographical shifting of cholera burden in Africa and its implications for disease controlJavier Perez-Saez, Qulu Zheng, Joshua Kaminsky, et al.Gynecologic Oncology|July 28, 2022
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ studyFlorence Joly, Michel Fabbro, Dominique Berton, et al.The Lancet. Oncology|August 8, 2020
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 studyXu-Shan Sun, Yungan Tao, Christophe Le Tourneau, et al.Biological Psychiatry|August 11, 2014
DNA modification study of major depressive disorder: beyond locus-by-locus comparisonsGabriel Oh, Sun-Chong Wang, Mrinal Pal, et al.Pageof 182